pam50 algorithm (NSABP Foundation)
Structured Review
Pam50 Algorithm, supplied by NSABP Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pam50+algorithm/pam50+classifier/pmc05903647-307-40-29
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Molecular intrinsic versus clinical subtyping in breast cancer: A comprehensive review. Article Snippet: Page of 66 Breast cancer is one of the primary causes of death in women, and it is the most common type of cancer in Canada and many other countries around the world 1,2.. It is estimated that in 2020, breast cancer cases would account for 25% of total new cancer cases in Canada 1,3.. Breast cancer is a heterogeneous disease manifesting diversity at the molecular, histological and clinical level 4. Article Title: Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups Article Snippet: The negative results for the identification of patients who would have no benefit from trastuzumab by PAM50-based molecular subgroups in the Adjuvant:Article Title: Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breast Tumors from the NCCTG (Alliance) N9831 Trial Article Snippet: .. Our data are broadly consistent with analyses of intrinsic subtype among HER2+ tumors from The Cancer Genome Atlas ( 10 ), the NOAH neoadjuvant ( 11 ), and the |
